<rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:digibug.ugr.es:10481/76701">
      <dc:title>Mesenchymal stem cells and cell-free preparations for treating atopic dermatitis</dc:title>
      <dc:creator>Montero Vílchez, Trinidad</dc:creator>
      <dc:creator>Sánchez Díaz, Manuel</dc:creator>
      <dc:creator>Montero Vílchez, Carolina</dc:creator>
      <dc:creator>Sierra Sánchez, Álvaro</dc:creator>
      <dc:creator>Arias Santiago, Salvador Antonio</dc:creator>
      <dc:subject>Atopic dermatitis</dc:subject>
      <dc:subject>Conditioned medium</dc:subject>
      <dc:subject>Dermatology</dc:subject>
      <dc:subject>Mesenchymal stem cells</dc:subject>
      <dc:subject>Stem cells</dc:subject>
      <dc:description>Atopic dermatitis (AD) is a chronic cutaneous inflammatory disease caused by an interaction between genetic,&#xd;
immune and epidermal barrier factors. Several treatments can be used to treat this disease but there are patients that do&#xd;
not respond to actual drugs. So, there is a need to develop effective therapies for AD. Mesenchymal stem cells (MSCs) are&#xd;
non-hematopoietic multipotent adult progenitor cells with immunomodulatory power and self-regenerating capacity to&#xd;
repair tissue damage, so they could be a potential effective treatment for AD. MSCs-Conditioned Medium (CM) and&#xd;
MSCs-exosomes are cell-free preparation with molecules secreted by stem cells that could be also beneficial for AD.&#xd;
This viewpoint reviews the actual development of MSCs, MSCs-CM and MSCs-exosomes for treating patients with AD.</dc:description>
      <dc:date>2022-09-15T07:32:23Z</dc:date>
      <dc:date>2022-09-15T07:32:23Z</dc:date>
      <dc:date>2022-07-07</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>MONTERO-VILCHEZ, T... [et al.] (2022). Mesenchymal stem cells and cell-free preparations for treating atopic dermatitis. BIOCELL, 46(11), 2363–2367. Doi: [10.32604/biocell.2022.021399]</dc:identifier>
      <dc:identifier>http://hdl.handle.net/10481/76701</dc:identifier>
      <dc:identifier>10.32604/biocell.2022.021399</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Atribución 4.0 Internacional</dc:rights>
      <dc:publisher>Tech Science</dc:publisher>
   </ow:Publication>
</rdf:RDF>